3rd Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues including the 340B program, the TRICARE Pharmacy Program, pharmaceutical supply chain, and COVID liability protection legislative proposals. Implementation of the Chronic Care Act of 2017. FDA Guidance on Alzheimer's drug development. H.R.6395/S.4049, National Defense Authorization Act for Fiscal Year 2021. Executive Order on Access to Affordable Life-saving Medications (E.O. 13937). Executive Order on Increasing Drug Importation to Lower Prices for American Patients (E.O. 13938). Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen (E.O. 13939). Executive Orders on Lowering Drug Prices by Putting America First (E.O. 13947, E.O. 13948). Executive Order on Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (E.O. 13944). Executive Order on An America-First Healthcare Plan (E.O. 13951).

LobbyistCovered position, as disclosed
KATHERINE DAPPER —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6395 (116th), S. 4049 (116th)

Trade (domestic/foreign) TRD

Issues related to prescription drug supply chains; H.R.6482/S.3537/S.3635, Protecting Our Pharmaceutical Supply Chain from China Act of 2020; H.R.6431, Made in America Emergency Preparedness Act.

LobbyistCovered position, as disclosed
KATHERINE DAPPER —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6482 (116th), H.R. 6431 (116th), S. 3635 (116th), S. 3537 (116th)

Medicare/Medicaid MMM

Part D Medicare Program including coverage for obesity medications. Proposed Part B IPI Demonstration Project. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; The HEALS Act; H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act.

LobbyistCovered position, as disclosed
KATHERINE DAPPER —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 8337 (116th), H.R. 19 (116th), H.R. 1425 (116th), H.R. 3 (116th), H.R. 6800 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.